المؤلفون: Bots, Sophie H, Schreuder, Michelle M, Roeters van Lennep, Jeanine E, Watson, Sarah, van Puijenbroek, Eugène, Onland-Moret, N Charlotte, den Ruijter, Hester M

المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, PECP - Centre for Pharmacoepidemiology

مصطلحات موضوعية: Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Male, Sex Characteristics

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/425737Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/425737Test

المؤلفون: The Blood Pressure Lowering Treatment Trialists' Collaboration

المساهمون: Cardiovasculaire Epi Team 5, Team Medisch, Circulatory Health, MS Orthopaedie Spine, MS CGO, Cancer

مصطلحات موضوعية: Angiotensin Receptor Antagonists/adverse effects, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Antihypertensive Agents/adverse effects, Blood Pressure/drug effects, Calcium Channel Blockers/adverse effects, Humans, Hypertension/complications, Neoplasms/chemically induced, Network Meta-Analysis, Randomized Controlled Trials as Topic, Risk Factors, Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/442581Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/442581Test

المؤلفون: Rudolph, Ulrike Maria, Enners, Salka, Kieble, Marita, Mahfoud, Felix, Böhm, Michael, Laufs, Ulrich, Schulz, Martin

المصدر: http://lobid.org/resources/99370678537906441Test#!, 35(10):903-911.

مصطلحات موضوعية: Hypertension/epidemiology [MeSH], Article, Hypertension/drug therapy [MeSH], Angiotensin Receptor Antagonists/adverse effects [MeSH], Antihypertensive Agents/adverse effects [MeSH], Humans [MeSH], Product Recalls and Withdrawals [MeSH], Angiotensin-Converting Enzyme Inhibitors [MeSH], Prognosis, Hypertension, Preventive medicine

العلاقة: https://repository.publisso.de/resource/frl:6471018Test; https://doi.org/10.1038/s41371-020-00425-zTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502678Test/

الإتاحة: https://doi.org/10.1038/s41371-020-00425-zTest
https://repository.publisso.de/resource/frl:6471018Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502678Test/

المؤلفون: Rachow, Tobias, Schiffl, Helmut, Lang, Susanne M.

المصدر: http://lobid.org/resources/99370674181806441Test#!, 147(1):195-204.

مصطلحات موضوعية: Renin–angiotensin–aldosterone system, Angiotensin-Converting Enzyme Inhibitors/adverse effects [MeSH], Non-small cell lung cancer, Review – Clinical Oncology, Angiotensin Receptor Antagonists/adverse effects [MeSH], Renin-Angiotensin System/drug effects [MeSH], Humans [MeSH], Lung Neoplasms/pathology [MeSH], Lung Neoplasms/epidemiology [MeSH], Angiotensin enzyme inhibitors, Angiotensin receptor blockers, Lung Neoplasms/chemically induced [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6469398Test; https://doi.org/10.1007/s00432-020-03445-xTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684567Test/

الإتاحة: https://doi.org/10.1007/s00432-020-03445-xTest
https://repository.publisso.de/resource/frl:6469398Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684567Test/

المؤلفون: Zolk, Oliver, Hafner, Susanne, Schmidt, Christoph Q.

المصدر: http://lobid.org/resources/99370679168606441Test#!, 393(7):1131-1135.

مصطلحات موضوعية: COVID-19, Coronavirus Infections/drug therapy [MeSH], Angiotensin-Converting Enzyme Inhibitors/adverse effects [MeSH], Non-steroidal anti-inflammatory agents, Pneumonia, Viral/virology [MeSH], Ibuprofen/pharmacology [MeSH], Angiotensin-converting enzyme inhibitors, Angiotensin-Converting Enzyme Inhibitors/pharmacology [MeSH], Angiotensin Receptor Antagonists/pharmacology [MeSH], Angiotensin receptor antagonists, SARS-CoV-2, Angiotensin-Converting Enzyme Inhibitors/administration, Dose-Response Relationship, Drug [MeSH], Renin-Angiotensin System/drug effects [MeSH], Angiotensin Receptor Antagonists/administration, Humans [MeSH], Anti-Inflammatory Agents, Non-Steroidal/administration, Review Article, Non-Steroidal/pharmacology [MeSH], Animals [MeSH], Betacoronavirus/isolation, Ibuprofen/adverse effects [MeSH], Pandemics [MeSH], Coronavirus Infections/virology [MeSH], Non-Steroidal/adverse effects [MeSH], Angiotensin Receptor Antagonists/adverse effects [MeSH], Ibuprofen/administration

العلاقة: https://repository.publisso.de/resource/frl:6466382Test; https://doi.org/10.1007/s00210-020-01890-6Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225250Test/

الإتاحة: https://doi.org/10.1007/s00210-020-01890-6Test
https://repository.publisso.de/resource/frl:6466382Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225250Test/

المؤلفون: Gulati, Geeta

المصدر: Hjerteforum. 30(1):64

المساهمون: College of Medicine, Dept. of Internal Medicine, Song-Yi Kim, Seung-Jae Joo, Mi-Seung Shin, Changsoo Kim, Eun Joo Cho, Ki-Chul Sung, Seok-Min Kang, Dong-Soo Kim, Seung Hwan Lee, Kyung-Kuk Hwang, Jeong Bae Park, Kang, Seok Min, Kim, Chang Soo

مصطلحات موضوعية: Adult, Aged, Ambulatory Care Facilities/statistics & numerical data, Angiotensin Receptor Antagonists/adverse effects, Angiotensin Receptor Antagonists/therapeutic use, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Biphenyl Compounds/adverse effects, Biphenyl Compounds/therapeutic use, Blood Pressure/drug effects, Blood Pressure Monitoring, Ambulatory/statistics & numerical data, Female, Hospitals, University, Humans, Hypertension/drug therapy, Middle Aged, Postmenopause, Prospective Studies, Pulse, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Republic of Korea, Tetrazoles/adverse effects, Tetrazoles/therapeutic use

وصف الملف: application/pdf

العلاقة: MEDICINE; J02214; OAK-2016-03325; https://ir.ymlib.yonsei.ac.kr/handle/22282913/147145Test; T201602211; MEDICINE, Vol.95(22) : 3764, 2016

الإتاحة: https://doi.org/10.1097/MD.0000000000003764Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/147145Test

المؤلفون: Kristensen, Soren L., Preiss, David, Jhund, Pardeep S., Squire, Iain, Cardoso, Jose Silva, Merkely, Bela, Martinez, Felipe, Starling, Randall C., Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J. V., Packer, Milton

المساهمون: Neyses, Ludwig

المصدر: Circulation: Heart Failure, 9 (1) (2016)

مصطلحات موضوعية: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome

العلاقة: urn:issn:1941-3297; https://orbilu.uni.lu/handle/10993/29587Test; info:hdl:10993/29587; https://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest; scopus-id:2-s2.0-84955319328; info:pmid:26754626; wos:000368624200001

الإتاحة: https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560Test
https://orbilu.uni.lu/handle/10993/29587Test
https://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest

المؤلفون: Lafaurie, M., Martin-Blondel, Guillaume, Delobel, Pierre, Charpentier, S., Sommet, A, Moulis, G.

المساهمون: Service Pharmacologie Clinique CHU Toulouse, Pôle Santé publique et médecine publique CHU Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre d'investigation clinique de Toulouse (CIC 1436), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Pôle Santé publique et médecine publique CHU Toulouse, Centre de Physiopathologie Toulouse Purpan (CPTP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service Maladies infectieuses et tropicales CHU Toulouse, Pôle Inflammation, infection, immunologie et loco-moteur CHU Toulouse (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)

المصدر: ISSN: 0767-3981.

مصطلحات موضوعية: angiotensin‐converting enzyme inhibitors, angiotensin‐receptor blockers, COVID‐19, SARS‐CoV‐2, pharmacoepidemiology, MESH: Aged, 80 and over, MESH: Angiotensin Receptor Antagonists / adverse effects, MESH: Respiration, Artificial, MESH: Treatment Outcome, MESH: Angiotensin-Converting Enzyme Inhibitors / adverse effects, MESH: COVID-19 / drug therapy, MESH: COVID-19 / enzymology, MESH: COVID-19 / mortality, MESH: Cardiovascular Diseases / complications, MESH: Cohort Studies, MESH: Critical Care, MESH: Female, MESH: France, MESH: Hospitalization, MESH: Humans, MESH: Hypertension / complications, MESH: Male, MESH: Peptidyl-Dipeptidase A / drug effects, MESH: Peptidyl-Dipeptidase A / metabolism, MESH: Propensity Score, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33111329; hal-03158926; https://ut3-toulouseinp.hal.science/hal-03158926Test; PUBMED: 33111329

الإتاحة: https://doi.org/10.1111/fcp.12613Test
https://ut3-toulouseinp.hal.science/hal-03158926Test

المؤلفون: Lapébie, François-Xavier, Bura-Rivière, Alessandra, Lacroix, Philippe, Constans, Joël, Boulon, Carine, Messas, Emmanuel, Aboyans, Victor, Ferrières, Jean, Bongard, Vanina

المساهمون: Service de Médecine Vasculaire CHU Toulouse, Pôle Cardiovasculaire et Métabolique CHU Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), STROMALab, Université de Toulouse (UT)-Université de Toulouse (UT)-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement Français du Sang-Centre National de la Recherche Scientifique (CNRS), Service de Chirurgie Thoracique et Vasculaire - Médecine vasculaire CHU Limoges, CHU Limoges, Neuroépidémiologie Tropicale (NET), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Service des Maladies Cardiaques et Vasculaires CHU Bordeaux, CHU Bordeaux, Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Service de cardiologie CHU Limoges, Fédération de Cardiologie CHU Toulouse, Service Cardiologie CHU Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Cardiovasculaire et Métabolique CHU Toulouse

المصدر: ISSN: 2055-6837.

مصطلحات موضوعية: Angiotensin receptor blockers, Angiotensin-converting enzyme inhibitors, Cohort studies, Mortality, Peripheral artery disease, MESH: Angiotensin Receptor Antagonists* / adverse effects, MESH: Angiotensin-Converting Enzyme Inhibitors* / adverse effects, MESH: Arteries, MESH: Cohort Studies, MESH: Hospitalization, MESH: Humans, MESH: Lower Extremity, MESH: Prospective Studies, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32271868; hal-04397543; https://ut3-toulouseinp.hal.science/hal-04397543Test; PUBMED: 32271868

الإتاحة: https://doi.org/10.1093/ehjcvp/pvaa026Test
https://ut3-toulouseinp.hal.science/hal-04397543Test